Cargando…

Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review

OBJECTIVES: In this paper, we emphasised that effective management of health plans beneficiaries access to reimbursed medicines requires proper institutional set-up. The main objective was to identify and recommend an institutional framework of integrated pharmaceutical care providing effective, saf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermanowski, Tomasz Roman, Drozdowska, Aleksandra Krystyna, Kowalczyk, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Uopen Journals 2015
Materias:	Policy Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628513/ https://www.ncbi.nlm.nih.gov/pubmed/26528099

Ejemplares similares

Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland
por: Drozdowska, Aleksandra, et al.
Publicado: (2015)

Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society
por: Drozdowska, Aleksandra, et al.
Publicado: (2014)

The Global Health System: Lessons for a Stronger Institutional Framework
por: Moon, Suerie, et al.
Publicado: (2010)

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020
por: Polak, Tobias B, et al.
Publicado: (2022)

BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres
por: van Ommen, Gert-Jan B, et al.
Publicado: (2015)

European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death
por: Fellmann, Florence, et al.
Publicado: (2019)

Soft Targets: Nurses and the Pharmaceutical Industry
por: Jutel, Annemarie, et al.
Publicado: (2008)

Integrating care for people with mental illness: the Care Programme Approach in England and its implications for long-term conditions management
por: Goodwin, Nick, et al.
Publicado: (2010)

Integrated primary health care in Greece, a missing issue in the current health policy agenda: a systematic review
por: Lionis, Christos, et al.
Publicado: (2009)

Increasing transparency and accountability in national pharmaceutical systems
por: Paschke, Anne, et al.
Publicado: (2018)

Conceptualizing Integration: A Framework for Analysis Applied to Neglected Tropical Disease Control Partnerships
por: Grépin, Karen A., et al.
Publicado: (2008)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document
por: Cornel, Martina C, et al.
Publicado: (2014)

A decade of integration and collaboration: the development of integrated health care in Sweden 2000–2010
por: Ahgren, Bengt, et al.
Publicado: (2011)

Integrated care organizations in Switzerland
por: Berchtold, Peter, et al.
Publicado: (2011)

Chronic and integrated care in Catalonia
por: Contel, Juan Carlos, et al.
Publicado: (2015)

Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
por: Fickweiler, Freek, et al.
Publicado: (2017)

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
por: Robertson, Jane, et al.
Publicado: (2009)

Divergent modes of integration: the Canadian way
por: Jiwani, Izzat, et al.
Publicado: (2011)

Integrated primary health care in Australia
por: Davies, Gawaine Powell, et al.
Publicado: (2009)

COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health
por: Ryan, Benjamin J., et al.
Publicado: (2020)

Opportunities for and constraints to integration of health services in Poland
por: Sobczak, Alicja
Publicado: (2002)

Integrated primary care in Germany: the road ahead
por: Schlette, Sophia, et al.
Publicado: (2009)

Telehealth Benefits and Barriers
por: Gajarawala, Shilpa N., et al.
Publicado: (2021)

Progress in the development of integrated mental health care in Scotland
por: Woods, Kevin, et al.
Publicado: (2002)

Ten years of integrated care for mental disorders in the Netherlands
por: van der Feltz-Cornelis, Christina M
Publicado: (2011)

Integrated primary health care: Finnish solutions and experiences
por: Kokko, Simo
Publicado: (2009)

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
por: Parker, Lisa, et al.
Publicado: (2019)

Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study
por: Satgunanathan, Kasthuri, et al.
Publicado: (2023)

Consumer-directed services: lessons and implications for integrated systems of care
por: L. Kodner, Dennis
Publicado: (2003)

Deinstitutionalisation of mental health care in the Netherlands: towards an integrative approach
por: Ravelli, Dick P.
Publicado: (2006)

Integrated mental health services in England: a policy paradox
por: England, Elizabeth, et al.
Publicado: (2005)

Integrated Control and Management of Neglected Tropical Skin Diseases
por: Mitjà, Oriol, et al.
Publicado: (2017)

Integrated disease management: arboviral infections and waterborne diarrhoea
por: Overgaard, Hans J, et al.
Publicado: (2021)

Investments in cancer research awarded to UK institutions and the global burden of cancer 2000–2013: a systematic analysis
por: Maruthappu, Mahiben, et al.
Publicado: (2017)

Chain of care development in Sweden: results of a national study
por: Åhgren, Bengt
Publicado: (2003)

Implementation process and challenges for the community-based integrated care system in Japan
por: Tsutsui, Takako
Publicado: (2014)

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
por: Gagnon, Marc-André, et al.
Publicado: (2008)

Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance
por: Milliken, Debbie, et al.
Publicado: (2015)

Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals
por: Cussans, Amelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4d2g3rq45023daacs40ee0j8j2